BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 33661465)

  • 1. Oocyte competence is independent of the ovulation trigger adopted: a large observational study in a setting that entails vitrified-warmed single euploid blastocyst transfer.
    Cimadomo D; Vaiarelli A; Petriglia C; Fabozzi G; Ferrero S; Schimberni M; Argento C; Colamaria S; Giuliani M; Ubaldi N; Rienzi L; Ubaldi FM
    J Assist Reprod Genet; 2021 Jun; 38(6):1419-1427. PubMed ID: 33661465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonist versus HCG triggering in different IVF/ICSI cycles of same patients: a retrospective study.
    Yılmaz N; Ceran MU; Ugurlu EN; Gülerman HC; Engin Ustun Y
    J Obstet Gynaecol; 2020 Aug; 40(6):837-842. PubMed ID: 31791167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ICSI-related procedural timings and operators on the outcome.
    Maggiulli R; Cimadomo D; Fabozzi G; Papini L; Dovere L; Ubaldi FM; Rienzi L
    Hum Reprod; 2020 Jan; 35(1):32-43. PubMed ID: 31916573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent live-birth rate in antagonist IVF/ICSI protocol after oocyte triggering with GnRH agonist supplemented with 1500 r-hCG the day of oocyte retrieval vs r-hCG : A case-control study.
    Cherrière F; Arvis P; Le Pabic E; Bidet M; Jaffré F; Guivarc'h-Levêque A
    J Gynecol Obstet Hum Reprod; 2020 Jun; 49(6):101702. PubMed ID: 32018042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Trigger for Final Follicular Maturation Improves Cumulative Live-Birth Rate in Ovarian Stimulation for Freeze-All
    Zhu H; Zhao C; Pan Y; Zhou H; Jin X; Xu W; Zhang S
    Front Endocrinol (Lausanne); 2021; 12():708247. PubMed ID: 34349729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M; Bogstad J; Løssl K; Prætorius L; Zedeler A; Bryndorf T; Nilas L; Pinborg A
    Hum Reprod; 2017 Mar; 32(3):556-567. PubMed ID: 28130435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition of a clinical strategy to enhance the efficacy, efficiency and safety of egg donation cycles with imported vitrified oocytes.
    Rienzi L; Cimadomo D; Maggiulli R; Vaiarelli A; Dusi L; Buffo L; Amendola MG; Colamaria S; Giuliani M; Bruno G; Stoppa M; Ubaldi FM
    Hum Reprod; 2020 Apr; 35(4):785-795. PubMed ID: 32240287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH triggering may improve euploidy and live birth rate in hyper-responders: a retrospective cohort study.
    Tan J; Jing C; Zhang L; Lo J; Kan A; Nakhuda G
    J Assist Reprod Genet; 2020 Aug; 37(8):1939-1948. PubMed ID: 32533431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcomes after frozen-thawed single euploid blastocyst transfer following IVF cycles using GNRH agonist or HCG trigger for final oocyte maturation.
    Makhijani R; Thorne J; Bartels C; Bartolucci A; Nulsen J; Grow D; Benadiva C; Engmann L
    J Assist Reprod Genet; 2020 Mar; 37(3):611-617. PubMed ID: 31897845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization.
    Elias RT; Pereira N; Artusa L; Kelly AG; Pasternak M; Lekovich JP; Palermo GD; Rosenwaks Z
    J Assist Reprod Genet; 2017 Jun; 34(6):781-788. PubMed ID: 28444614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.
    Lin MH; Wu FS; Hwu YM; Lee RK; Li RS; Li SH
    Reprod Biol Endocrinol; 2019 Jan; 17(1):7. PubMed ID: 30609935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
    Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves
    Mutlu I; Demirdag E; Cevher F; Erdem A; Erdem M
    J Obstet Gynaecol; 2022 Jul; 42(5):1239-1244. PubMed ID: 34565274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing: observational longitudinal cohort study of 1,219 consecutive cycles.
    Mazzilli R; Cimadomo D; Vaiarelli A; Capalbo A; Dovere L; Alviggi E; Dusi L; Foresta C; Lombardo F; Lenzi A; Tournaye H; Alviggi C; Rienzi L; Ubaldi FM
    Fertil Steril; 2017 Dec; 108(6):961-972.e3. PubMed ID: 28985908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The euploid blastocysts obtained after luteal phase stimulation show the same clinical, obstetric and perinatal outcomes as follicular phase stimulation-derived ones: a multicenter study.
    Vaiarelli A; Cimadomo D; Alviggi E; Sansone A; Trabucco E; Dusi L; Buffo L; Barnocchi N; Fiorini F; Colamaria S; Giuliani M; Argento C; Rienzi L; Ubaldi FM
    Hum Reprod; 2020 Nov; 35(11):2598-2608. PubMed ID: 32951051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.